{Reference Type}: Journal Article
{Title}: Disparities in glioblastoma survival by case volume: a nationwide observational study.
{Author}: Raj R;Seppä K;Luostarinen T;Malila N;Seppälä M;Pitkäniemi J;Korja M;
{Journal}: J Neurooncol
{Volume}: 147
{Issue}: 2
{Year}: Apr 2020
{Factor}: 4.506
{DOI}: 10.1007/s11060-020-03428-5
{Abstract}: <B>BACKGROUND: </B>High hospital case volumes are associated with improved treatment outcomes for numerous diseases. We assessed the association between academic non-profit hospital case volume and survival of adult glioblastoma patients.<BR><B>METHODS: </B>From the nationwide Finnish Cancer Registry, we identified all adult (≥ 18 years) patients with histopathological diagnoses of glioblastoma from 2000 to 2013. Five university hospitals (treating all glioblastoma patients in Finland) were classified as high-volume (one hospital), middle-volume (one hospital), and low-volume (three hospitals) based on their annual numbers of cases. We estimated one-year survival rates, estimated median overall survival times, and compared relative excess risk (RER) of death between high, middle, and low-volume hospitals.<BR><B>RESULTS: </B>A total of 2,045 patients were included. The mean numbers of annually treated patients were 54, 40, and 17 in the high, middle, and low-volume hospitals, respectively. One-year survival rates and median survival times were higher and longer in the high-volume (39%, 9.3 months) and medium-volume (38%, 8.9 months) hospitals than in the low-volume (32%, 7.8 months) hospitals. RER of death was higher in the low-volume hospitals than in the high-volume hospital (RER = 1.19, 95% CI 1.07-1.32, p = 0.002). There was no difference in RER of death between the high-volume and medium-volume hospitals (p = 0.690).<BR><B>CONCLUSIONS: </B>Higher glioblastoma case volumes were associated with improved survival. Future studies should assess whether this association is due to differences in patient-specific factors or treatment quality.